Literature DB >> 20488796

NK cell regulation of CD4 T cell-mediated graft-versus-host disease.

Magali Noval Rivas1, Marc Hazzan, Kathleen Weatherly, Florence Gaudray, Isabelle Salmon, Michel Y Braun.   

Abstract

CD3-negative NK cells are granular lymphocytes capable of producing inflammatory cytokines and killing malignant, infected, or stressed cells. We have recently observed a new role for NK cells in the control of the proliferation of CD4 T cells under persistent antigenic stimulation. Monoclonal anti-male CD4 T cells transferred into Rag2-/- male recipients did not expand or were rapidly eliminated. Remarkably, T cells transferred into NK cell-deficient Rag2-/- Il-2Rgammac-/- male hosts expanded extensively and mediated tissue lesions usually observed in chronic graft-versus-host disease (GVHD). T cell failure to proliferate and to induce chronic GVHD was the result of NK cell activity, because depletion of the recipient's NK1.1+ cells by Ab treatment induced T cell expansion and chronic GVHD. T cells under chronic Ag stimulation upregulated ligands of the activating receptor NKG2D, and regulatory activity of NK cells was inhibited by the injection of Abs directed to NKG2D. On the contrary, blocking NKG2A inhibitory receptors did not increase NK cell regulatory activity. Finally, we show that NK regulation of T cell expansion did not involve perforin-mediated lytic activity of NK cells, but depended on T cell surface expression of a functional Fas molecule. These results highlight the potential role played by NK cells in controlling the Ag-specific CD4+ T cells responsible for chronic GVHD.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20488796     DOI: 10.4049/jimmunol.0902598

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  44 in total

Review 1.  Targeted immunotherapy for acute myeloid leukemia.

Authors:  Sumithira Vasu; Michael A Caligiuri
Journal:  Best Pract Res Clin Haematol       Date:  2011-11-11       Impact factor: 3.020

Review 2.  Acute graft-versus-host disease: a bench-to-bedside update.

Authors:  Shernan G Holtan; Marcelo Pasquini; Daniel J Weisdorf
Journal:  Blood       Date:  2014-06-09       Impact factor: 22.113

3.  Allogeneic Reduced-Intensity Hematopoietic Stem Cell Transplantation for Chronic Granulomatous Disease: a Single-Center Prospective Trial.

Authors:  Mark Parta; Corin Kelly; Nana Kwatemaa; Narda Theobald; Diane Hilligoss; Jing Qin; Douglas B Kuhns; Christa Zerbe; Steven M Holland; Harry Malech; Elizabeth M Kang
Journal:  J Clin Immunol       Date:  2017-07-28       Impact factor: 8.317

4.  T-bet Promotes Acute Graft-versus-Host Disease by Regulating Recipient Hematopoietic Cells in Mice.

Authors:  Jianing Fu; Yongxia Wu; Hung Nguyen; Jessica Heinrichs; Steven Schutt; Yuejun Liu; Chen Liu; Junfei Jin; Claudio Anasetti; Xue-Zhong Yu
Journal:  J Immunol       Date:  2016-02-22       Impact factor: 5.422

5.  Effect of the in vivo application of granulocyte colony-stimulating factor on NK cells in bone marrow and peripheral blood.

Authors:  Xing-Xing Yu; Ting-Ting Han; Ling-Ling Xu; Ying-Jun Chang; Xiao-Jun Huang; Xiang-Yu Zhao
Journal:  J Cell Mol Med       Date:  2018-03-25       Impact factor: 5.310

6.  Early and late extensive chronic graft-versus-host disease in children is characterized by different Th1/Th2 cytokine profiles: findings of the Children's Oncology Group Study ASCT0031.

Authors:  Jacob Rozmus; Kirk R Schultz; Kristin Wynne; Amina Kariminia; Preeti Satyanarayana; Mark Krailo; Stephan A Grupp; Andrew L Gilman; Frederick D Goldman
Journal:  Biol Blood Marrow Transplant       Date:  2011-05-25       Impact factor: 5.742

7.  Recipient NK cell inactivation and intestinal barrier loss are required for MHC-matched graft-versus-host disease.

Authors:  Sam C Nalle; H Aimee Kwak; Karen L Edelblum; Nora E Joseph; Gurminder Singh; Galina F Khramtsova; Eric D Mortenson; Peter A Savage; Jerrold R Turner
Journal:  Sci Transl Med       Date:  2014-07-02       Impact factor: 17.956

Review 8.  Chronic graft-versus-host disease: biological insights from preclinical and clinical studies.

Authors:  Kelli P A MacDonald; Geoffrey R Hill; Bruce R Blazar
Journal:  Blood       Date:  2016-11-07       Impact factor: 22.113

Review 9.  Emerging immunotherapies in older adults with acute myeloid leukemia.

Authors:  Sumithira Vasu; William Blum
Journal:  Curr Opin Hematol       Date:  2013-03       Impact factor: 3.284

10.  Memory CD4+ T cells are required for optimal NK cell effector functions against the opportunistic fungal pathogen Pneumocystis murina.

Authors:  Michelle N Kelly; Mingquan Zheng; Sanbao Ruan; Jay Kolls; Alain D'Souza; Judd E Shellito
Journal:  J Immunol       Date:  2012-11-30       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.